COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital Post published:July 5, 2023 Post category:Press Release
COMPASS Pathways to participate in upcoming Cantor Fitzgerald and HC Wainwright investor conferences Post published:June 16, 2023 Post category:Press Release
COMPASS Pathways’ key patents upheld by the US Patent and Trademark Office Post published:June 6, 2023 Post category:Press Release
COMPASS Pathways’ Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer Post published:May 31, 2023 Post category:Press Release
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference Post published:May 27, 2023 Post category:Press Release
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023 Post published:May 26, 2023 Post category:Press Release
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights Post published:May 11, 2023 Post category:Press Release
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023 Post published:May 3, 2023 Post category:Press Release
American Medical Association to Issue First New Code for Psychedelic Therapies Post published:May 2, 2023 Post category:Press Release
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference Post published:April 10, 2023 Post category:Press Release